The Centers for Medicare and Medicaid Services will host a series of private interactive roundtable discussions with patients, caregivers and patient advocates in the spring, instead of public forums, to gather input on the next round of drugs chosen for negotiation.
Key Takeaways
-
CMS plans to hold 15 roundtable sessions with patients, caregivers and patient advocates next spring to gather input on the next group of Medicare Part D drugs that will be selected for price negotiation, according to final guidance on the process.
Final guidance on the negotiation process released 2 October covers some changes to the negotiation process for prices that...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?